Myocardial revascularization: the evolution of the STS database and quality measurement for improvement

  • Reilly Daniel Hobbs
  • Gaetano Paone
  • Richard Salvatore D’Agostino
  • Jeffrey Phillip Jacobs
  • Donna Eileen McDonald
  • Richard Laurence PragerEmail author
  • David Michael Shahian
Review Article


The Society of Thoracic Surgeons (STS) is a not-for-profit organization dedicated to helping clinicians and researchers provide optimal outcomes for patients undergoing heart, lung, and esophageal surgery. The organization was founded in 1964 and has grown to now include over 7300 members in over 90 countries. The STS created a national database that collects detailed clinical information on patients undergoing adult cardiac, pediatric and congenital cardiac, and general thoracic operations. The data collected are used to produce risk-adjusted, nationally benchmarked performance assessments and feedback; facilitate voluntary public reporting; support quality initiatives; develop evidence-based guidelines; monitor long-term clinical outcomes; track device performance; and promote high-quality research collaboratives.


Society of Thoracic Surgeons Surgery Myocardial revascularization 


Compliance with ethical standards

Ethical approval

IRB for Human and Animal rights were not required.

Informed consent


Conflict of interest

The authors declare that they have no conflict of interest.


  1. 1.
    Winkley Shroyer AL, Bakaeen F, Shahian DM, et al. The Society of Thoracic Surgeons Adult Cardiac Surgery Database: The Driving Force for Improvement in Cardiac Surgery. Semin Thorac Cardiovasc Surg. 2015;27:144–51. Scholar
  2. 2.
    Shahian DM, Jacobs JP, Edwards FH, et al. The society of thoracic surgeons national database. Heart. 2013;99:1494–501. Scholar
  3. 3.
    Anderson RP. First publications from The Society of Thoracic Surgeons National Database. Ann Thorac Surg. 1994;57:6–7. Scholar
  4. 4.
    Clark RE. It is time for a national cardiothoracic surgical data base. Ann Thorac Surg. 1989;48:755–6.CrossRefGoogle Scholar
  5. 5.
    D’Agostino RS, Jacobs JP, Badhwar V, et al. The Society of Thoracic Surgeons Adult Cardiac Surgery Database: 2018 Update on Outcomes and Quality. Ann Thorac Surg. 2018;105:15–23. Scholar
  6. 6.
    Shahian DM, O’Brien SM, Filardo G, et al. The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 1--coronary artery bypass grafting surgery. Ann Thorac Surg. 2009;88:S2–22. CrossRefGoogle Scholar
  7. 7.
    Shahian DM, Edwards FH. The Society of Thoracic Surgeons 2008 Cardiac Surgery Risk Models: Introduction. Ann Thorac Surg. 2009;88:S1. Scholar
  8. 8.
    O’Brien SM, Shahian DM, Filardo G, et al. The Society of Thoracic Surgeons 2008 cardiac surgery risk models: Part 2-isolated valve surgery. Ann Thorac Surg. 2009;88:S23–42. Scholar
  9. 9.
    Vassileva CM, Aranki S, Brennan JM, et al. Evaluation of the society of thoracic surgeons online risk calculator for assessment of risk in patients presenting for aortic valve replacement after prior coronary artery bypass graft: An analysis using the STS Adult Cardiac Surgery Database. Ann. Thorac. Surg. 2015;100:2109–15. Scholar
  10. 10.
    D’Agostino RS, Jacobs JP, Badhwar V, et al. The Society of Thoracic Surgeons adult cardiac surgery database: 2017 update on outcomes and quality. Ann Thorac Surg. 2017;103:18–24. Scholar
  11. 11.
    Shahian DM, O’Brien SM, Filardo G, et al. The Society of Thoracic Surgeons 2008 cardiac surgery risk models: Part 3—valve plus coronary artery bypass grafting surgery. Ann Thorac Surg. 2009;88:S43–62. CrossRefGoogle Scholar
  12. 12.
    Jin R, Furnary AP, Fine SC, Blackstone EH, Grunkemeier GL. Using Society of Thoracic Surgeons risk models for risk-adjusting cardiac surgery results. Ann Thorac Surg. 2010;89:677–82. Scholar
  13. 13.
    Shahian DM, Jacobs JP, Badhwar V, D’Agostino RS, Bavaria JE, Prager RL. Risk aversion and public reporting. Part 1: observations from cardiac surgery and interventional cardiology. Ann Thorac Surg. 2017;104:2093–101. Scholar
  14. 14.
    Caceres M, Braud RL, Garrett HE. A short history of the Society of Thoracic Surgeons National Cardiac Database: Perceptions of a practicing surgeon. Ann Thorac Surg. 2010;89:332–9. Scholar
  15. 15.
    Ferris TG, Torchiana DF. Public release of clinical outcomes data—online CABG report cards. N Engl J Med. 2010;363:1593–5. Scholar
  16. 16.
    Mariscalco G, Engström KG. Atrial fibrillation after cardiac surgery: Risk factors and their temporal relationship in prophylactic drug strategy decision. Int J Cardiol. 2008;129:354–62. Scholar
  17. 17.
    Bramer S, van Straten AHM, Soliman Hamad MA, Berreklouw E, Martens EJ, Maessen JG. The impact of preoperative atrial fibrillation on early and late mortality after coronary artery bypass grafting. Eur J Cardio-Thoracic Surg. 2010;38:373–9. Scholar
  18. 18.
    Burgess DC, Kilborn MJ, Keech AC. Interventions for prevention of post-operative atrial fibrillation and its complications after cardiac surgery: A meta-analysis. Eur Heart J. 2006;27:2846–57. Scholar
  19. 19.
    Kulik A, Ruel M, Jneid H, Ferguson TB, et al. Secondary prevention after coronary artery bypass graft surgery: A scientific statement from the American Heart Association. Circulation. 2015;131:927–64. Scholar
  20. 20.
    Brinkman W, Herbert MA, O’Brien S, et al. Preoperative β-Blocker use in coronary artery bypass grafting surgery.national database analysis. JAMA Intern Med. 2014;174:1320–7. CrossRefGoogle Scholar
  21. 21.
    LaPar DJ, Crosby IK, Kron IL, et al. Preoperative beta-blocker use should not be a quality metric for coronary artery bypass grafting. Ann Thorac Surg. 2013;96:1539–44.CrossRefGoogle Scholar
  22. 22.
    Shahian DM. Preoperative β-blockade in coronary artery bypass grafting surgery. JAMA Intern Med. 2014;174:1328–9.CrossRefGoogle Scholar
  23. 23.
    Sun C, Zhang H, Zheng Z. Efficacy of β-blocker therapy for secondary prevention for patients undergoing coronary artery bypass grafting surgery. Curr Opin Cardiol. 2016;31:654–61.CrossRefGoogle Scholar
  24. 24.
    Ferguson TB, Coombs LP, Peterson ED. Society of Thoracic Surgeons National Adult Cardiac Surgery Database. Preoperative beta-blocker use and mortality and morbidity following CABG surgery in North America. JAMA. 2002;287:2221–7.CrossRefGoogle Scholar
  25. 25.
    Chan AYM, McAlister FA, Norris CM, Johnstone D, Bakal JA, Ross DB. Effect of beta-blocker use on outcomes after discharge in patients who underwent cardiac surgery. J Thorac Cardiovasc Surg. 2010;140:182–7.CrossRefGoogle Scholar
  26. 26.
    Zeinah M, Elghanam M, Benedetto U. Which beta-blocker should be used for the prevention of postoperative atrial fibrillation in cardiac surgery? A multi-treatment benefit-risk meta-analysis. Egypt Hear J. 2016;68:89–96.CrossRefGoogle Scholar
  27. 27.
    Foody JM, Ferdinand FD, Galusha D, et al. Patterns of secondary prevention in older patients undergoing coronary artery bypass grafting during hospitalization for acute myocardial infarction. Circulation. 2003;108:24–8.CrossRefGoogle Scholar
  28. 28.
    Goff DC, Lloyd-Jones DM, Bennett G, et al. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: A report of the American college of cardiology/American heart association task force on practice guidelines. Circulation. 2014;129:S49–73. Scholar
  29. 29.
    Kulik A, Brookhart MA, Levin R, Ruel M, Solomon DH, Choudhry NK. Impact of statin use on outcomes after coronary artery bypass graft surgery. Circulation. 2008;118:1785–92. Scholar
  30. 30.
    Pan W, Pintar T, Anton J, Lee VV, Vaughn WK, Collard CD. Statins are associated with a reduced incidence of perioperative mortality after coronary artery bypass graft surgery. Circulation. 2004;110:II45–I49.Google Scholar
  31. 31.
    Campeau L. Lipid lowering and coronary bypass graft surgery. Curr Opin Cardiol. 2000;15:395–9.CrossRefGoogle Scholar
  32. 32.
    Motwani JG, Topol EJ. Aortocoronary saphenous vein graft disease: Pathogenesis, predisposition, and prevention. Circulation. 1998;97:916–31.CrossRefGoogle Scholar
  33. 33.
    Investigators TPCABGT. The effect of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation on obstructive changes in saphenous-vein coronary-artery bypass grafts. N Engl J Med. 1997;336:153–62.CrossRefGoogle Scholar
  34. 34.
    Abramov D, Tamariz MG, Sever JY, et al. The influence of gender on the outcome of coronary artery bypass surgery. Ann Thorac Surg. 2000;70:800–5.CrossRefGoogle Scholar
  35. 35.
    Cohn L. Use of the internal mammary artery graft and in-hospital mortality and other adverse outcomes associated with coronary artery bypass surgery. Circulation. 2001;103:483–4.CrossRefGoogle Scholar
  36. 36.
    Loop FD, Lytle BW, Cosgrove DM, et al. Influence of the internal-mammary-artery graft on 10-year survival and other cardiac events. N Engl J Med. 1986;314:1–6.CrossRefGoogle Scholar
  37. 37.
    Engelman DT, Cohn LH, Rizzo RJ. Incidence and predictors of TIAs and strokes following coronary artery bypass grafting: report and collective review. Heart Surg Forum. 1999;2:242–5.Google Scholar
  38. 38.
    Puskas JD, Winston AD, Wright CE, et al. Stroke after coronary artery operation: Incidence, correlates, outcome, and cost. Ann Thorac Surg. 2000;69:1053–6.CrossRefGoogle Scholar
  39. 39.
    Shroyer AL, Coombs LP, Peterson ED, et al. The Society of Thoracic Surgeons: 30-day operative mortality and morbidity risk models. Ann Thorac Surg. 2003;75:1856–64.CrossRefGoogle Scholar
  40. 40.
    Welke KF, Ferguson TB, Coombs LP, et al. Validity of the Society of Thoracic Surgeons National Adult Cardiac Surgery Database. Ann Thorac Surg. 2004;77:1137–9.CrossRefGoogle Scholar
  41. 41.
    Karthik S, Grayson AD, McCarron EE, Pullan DM, Desmond MJ. Reexploration for bleeding after coronary artery bypass surgery: risk factors, outcomes, and the effect of time delay. Ann Thorac Surg. 2004;78:527–34.CrossRefGoogle Scholar
  42. 42.
    Mehta RH, Sheng S, O’Brien SM, et al. Reoperation for bleeding in patients undergoing coronary artery bypass surgery: Incidence, risk factors, time trends, and outcomes. Circ Cardiovasc Qual Outcomes. 2009;2:583–90. Scholar
  43. 43.
    Olsen MA, Lock-Buckley P, Hopkins D, Polish LB, Sundt TM, Fraser VJ. The risk factors for deep and superficial chest surgical-site infections after coronary artery bypass graft surgery are different. J Thorac Cardiovasc Surg. 2002;124:136–45. Scholar
  44. 44.
    Kubota H, Miyata H, Motomura N, et al. Deep sternal wound infection after cardiac surgery. J Cardiothorac Surg. 2013;8:132. Scholar
  45. 45.
    Tang GH, Maganti M, Weisel RD, Borger MA. Prevention and management of deep sternal wound infection. Semin Thorac Cardiovasc Surg. 2004;16:62–9.CrossRefGoogle Scholar
  46. 46.
    Braxton JH, Marrin CAS, McGrath PD, et al. 10-Year follow-up of patients with and without mediastinitis. Semin Thorac Cardiovasc Surg. 2004;16:70–6. Scholar
  47. 47.
    Conlon PJ, Stafford-Smith M, White WD, et al. Acute renal failure following cardiac surgery. Nephrol Dial Transplant. 1999;14:1158–62.CrossRefGoogle Scholar
  48. 48.
    Chertow GM, Levy EM, Hammermeister KE, Grover F, Daley J. Independent association between acute renal failure and mortality following cardiac surgery. Am J Med. 1998;104:343–8.CrossRefGoogle Scholar
  49. 49.
    Mangano CM, Diamondstone LS, Ramsay JG, Aggarwal A, Herskowitz A, Mangano DT. Renal dysfunction after myocardial revascularization: risk factors, adverse outcomes, and hospital resource utilization. The Multicenter Study of Perioperative Ischemia Research Group. Ann Intern Med. 1998;128:194–203.CrossRefGoogle Scholar
  50. 50.
    Coca SG, Yusuf B, Shlipak MG, Garg AX, Parikh CR. Long-term risk of mortality and other adverse outcomes after acute kidney Injury: A Systematic Review and Meta-analysis. Am J Kidney Dis. 2009;53:961–73. Scholar
  51. 51.
    Naughton C, Reilly N, Powroznyk A, et al. Factors determining the duration of tracheal intubation in cardiac surgery: A single-centre sequential patient audit. Eur J Anaesthesiol. 2003;20:225–33.CrossRefGoogle Scholar
  52. 52.
    Speir AM, Kasirajan V, Barnett SD, Fonner E. Additive costs of postoperative complications for isolated coronary artery bypass grafting patients in Virginia. Ann Thorac Surg. 2009;88:40–6. Scholar
  53. 53.
    Brown PP, Kugelmass AD, Cohen DJ, et al. The frequency and cost of complications associated with coronary artery bypass grafting surgery: results from the United States Medicare program. Ann Thorac Surg. 2008;85:1980–6.CrossRefGoogle Scholar
  54. 54.
    Engelman R, Shahian D, Shemin R, et al. The Society of Thoracic Surgeons practice guideline series: Antibiotic prophylaxis in cardiac surgery, part II: Antibiotic choice. AnnThorac Surg. 2007;83:1569–76.CrossRefGoogle Scholar
  55. 55.
    Austin TW, Coles JC, Burnett R, Goldbach M. Aortocoronary bypass procedures and sternotomy infections: A study of antistaphylococcal prophylaxis. Can J Surg. 1980;23:483–5.Google Scholar
  56. 56.
    Buxton BF, Shi WY, Tatoulis J, Fuller JA, Rosalion A, Hayward PA. Total arterial revascularization with internal thoracic and radial artery grafts in triple-vessel coronary artery disease is associated with improved survival. J Thorac Cardiovasc Surg. 2014;148:1238–43. Scholar
  57. 57.
    Zacharias A, Schwann TA, Riordan CJ, Durham SJ, Shah AS, Habib RH. Late Results of Conventional Versus All-Arterial Revascularization Based on Internal Thoracic and Radial Artery Grafting. Ann Thorac Surg. 2009;87:19–26. Scholar
  58. 58.
    Gaudino M, Benedetto U, Fremes S, et al. Radial-Artery or Saphenous-Vein Grafts in Coronary-Artery Bypass Surgery. N Engl J Med. 2018;378:2069–77. Scholar
  59. 59.
    Aldea GS, Bakaeen FG, Pal J, et al. The Society of Thoracic Surgeons clinical practice guidelines on arterial conduits for coronary artery bypass grafting. Ann Thorac Surg. 2016;101:801–9.CrossRefGoogle Scholar

Copyright information

© Indian Association of Cardiovascular-Thoracic Surgeons 2018

Authors and Affiliations

  • Reilly Daniel Hobbs
    • 1
  • Gaetano Paone
    • 2
  • Richard Salvatore D’Agostino
    • 3
  • Jeffrey Phillip Jacobs
    • 4
    • 5
  • Donna Eileen McDonald
    • 6
  • Richard Laurence Prager
    • 1
    Email author
  • David Michael Shahian
    • 7
  1. 1.Department of Cardiac SurgeryUniversity of MichiganAnn ArborUSA
  2. 2.Division of Cardiac SurgeryHenry Ford HospitalDetroitUSA
  3. 3.Department of Thoracic and Cardiovascular SurgeryLahey Hospital & Medical CenterBurlingtonUSA
  4. 4.The Congenital Heart Institute of Florida (CHIF), All Children’s HospitalUniversity of South Florida College of MedicineSaint PetersburgUSA
  5. 5.The Congenital Heart Institute of Florida (CHIF), All Children’s HospitalUniversity of South Florida College of MedicineTampaUSA
  6. 6.The Society of Thoracic SurgeonsChicagoUSA
  7. 7.Center for Quality and Safety and Department of SurgeryMassachusetts General HospitalBostonUSA

Personalised recommendations